Scorpius Holdings, Inc.
Company Information
Industry
Pharmaceutical Preparations
SIC Code
2834
Entity Type
operating
SEC Category
Non-accelerated filerSmaller reporting company
State of Incorporation
DE
Business Address
1305 E. HOUSTON STREET, SAN ANTONIO, TX, 78205
Mailing Address
1305 E. HOUSTON STREET, SAN ANTONIO, TX, 78205
Phone
919-240-7133
Fiscal Year End
1231
EIN
262844103
Financial Overview
FY2024
-$32.81M
Net Income
$1.03M
Cash & Equivalents
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 8-K Current report of material events | March 19, 2026 | View on SEC |
| 8-K/A Current report amendment | March 10, 2026 | View on SEC |
| 10-Q Quarterly financial report | February 17, 2026 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | February 5, 2026 | View on SEC |
| 8-K Current report of material events | January 29, 2026 | View on SEC |
| 8-K Current report of material events | January 13, 2026 | View on SEC |
| 10-Q Quarterly financial report | January 12, 2026 | View on SEC |
| 8-K Current report of material events | December 3, 2025 | View on SEC |
| 8-K Current report of material events | December 2, 2025 | View on SEC |
| 8-K Current report of material events | November 25, 2025 | View on SEC |
Material Events
8-K
Financial Distress
January 29, 2026
High Impact
- Foreclosure of nearly all core business assets, including CDMO, R&D, and key operating subsidiaries.
- Company has effectively lost its primary revenue-generating operations and can no longer conduct core business activities.
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.